Articles

One reason I’m wary of Medicare Advantage? I’m a capitalist.

The downside of Medicare Advantage is that you are dependent for your health-insurance coverage on an organization that has powerful economic incentives not to pay.

Why U.S.-Russia tensions have sent palladium prices soaring

Palladium futures rallied Thursday to their highest price of the year, buoyed by the suggestion of sanctions on exports of the metal from Russia, which is the world’s largest exporter.

Jamie Dimon worries ‘World War III has already begun’

Adversaries of the United States “are clearly talking about dismantling the system,” the JPMorgan Chase CEO notes.

Why stock investors have been on edge over the prospects of a total sweep for Republicans

A so-called “red wave” sweep of the White House and Congress would most likely make it easier to pass the Republican Party’s agenda, according to market participants.

Boeing’s CEO wants to make it ‘great again.’ Here’s what’s standing in the way.

Making Boeing great again starts with a labor deal, according to Wall Street analysts.

AT&T’s stock is beating Verizon’s by a lot in 2024. Here’s where analysts stand.

Half of analysts are bullish on AT&T’s stock, which is roughly the same as what it is for Verizon’s.

Mortgage rates rise for the fourth week in a row. But in these states, it’s still cheaper to buy than to rent.

The 30-year mortgage rate is averaging at 6.54%, Freddie Mac said in its latest weekly survey on Thursday.

Rocket Lab stock climbs more than 6% after KeyBanc raises price target

Shares of Rocket Lab USA Inc. are up 6.1% Thursday after KeyBanc Capital Markets raised its price target for the space-launch company.

‘I don’t trust my financial guy.’ I’m 67 and trying to live on $2.2K-a-month Social Security. I have $500K with an adviser, who charges 2%, but last year the return was 26%. What’s my move?

We spotted a lot of too-common red flags.

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings that showed enough cash on its balance sheet to fund key clinical trials.

Polymarket says the whale betting heavily on Trump is a French individual

The mystery bettor making large trades on former President Donald Trump to win the election on a cryptocurrency site is a French national who is doing so based on personal belief, the site Polymarket said Thursday, according to multiple reports.

The Russell 2000 is flawed — this ETF plays it in a better way for quality

If you research an actively managed mutual fund or exchange-traded fund that invests in small-cap stocks, it is most likely that the benchmark against which the fund management firm measures its performance is the Russell 2000 Index. But this index can be considered to be of low quality, because it includes a large number of unprofitable companies.
1 87 88 89 90 91 1,732